Ford (F.US) plans to cut 1,000 jobs at its electric car factory in Cologne, Germany.
Due to lower than expected demand for electric vehicles in Europe, Ford Motor Company (F.US) plans to cut up to 1000 jobs at its electric vehicle production factory in Cologne, Germany.
Due to lower-than-expected demand for electric cars in Europe, Ford Motor Company (F.US) plans to cut up to 1000 jobs at its electric car production plant in Cologne, Germany.
Ford added that starting from January 2026, the Cologne plant will switch to single-shift production, with the job adjustments expected as a result.
Ford stated: "In Europe, demand for electric cars is still far below industry expectations." "Therefore, Ford will adjust the production mode of the Cologne plant to single-shift starting from January 2026."
Previously, Ford had invested billions of dollars to transform the Cologne plant into an electric car production center, but soft demand for electric cars led to a decrease in factory output and manpower needs. The background to this layoff measure is that the entire automotive industry is facing multiple challenges, including low penetration rate of electric cars, high initial investment costs, and tariff-related difficulties.
Related Articles

US Stock Market Move | Fangdd Network Group Ltd Sponsored ADR Class A(DUO.US) surged 13%, narrowing the month-on-month decline in sales prices of residential properties in top and second-tier cities in August.

DL HOLDINGS GP (01709) further subscribed to 15.10% Class B membership interests of Carmel Reserve LLC.

US Stock Market Move | Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rises more than 2% on positive Phase III trial results of new generation weight-loss drug Cagrilintide.
US Stock Market Move | Fangdd Network Group Ltd Sponsored ADR Class A(DUO.US) surged 13%, narrowing the month-on-month decline in sales prices of residential properties in top and second-tier cities in August.

DL HOLDINGS GP (01709) further subscribed to 15.10% Class B membership interests of Carmel Reserve LLC.

US Stock Market Move | Novo Nordisk A/S Sponsored ADR Class B (NVO.US) rises more than 2% on positive Phase III trial results of new generation weight-loss drug Cagrilintide.
